Skip to content

Clinical trials

Amyloidosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyloidosis Clear all

253 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20021
20032
20053
20062
20074
20087
20096
20104
201110
20123
201311
20149
20155
201615
20178
201813
201917
202019
202124
202214
202317
202415
202518
202616

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed115
Recruiting53
Unknown status23
Terminated17
Withdrawn15
Active, not recruiting13
Not yet recruiting10
Enrolling by invitation4
No longer available1
Available1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alnylam Pharmaceuticals14
Mayo Clinic10
GlaxoSmithKline9
Brigham and Women's Hospital8
Eidos Therapeutics, a BridgeBio company8
Pfizer8
Fondazione IRCCS Policlinico San Matteo di Pavia7
Ionis Pharmaceuticals, Inc.7
The Cleveland Clinic5
Tufts Medical Center4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyloidosis253
Amyloid Neuropathies, Familial50
Immunoglobulin Light-chain Amyloidosis50
Cardiomyopathies33
Alzheimer Disease27
Multiple Myeloma25
Polyneuropathies19
Amyloidosis, Familial17
Heart Failure10
Amyloid Neuropathies7

Trials

Showing 51 to 75 of 253. Each trial links to its page on Pharma Observatory.

153 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.